Date Modified

2025-07-02

Period

24/months

Report Summary

• Trial commenced on 24.05.2023 • Recruitment status: Recruitment complete: follow up complete • Number assessed for eligibility:81 • Number recruited and allocated/ randomized: 79 • Date of trial completion: 21.08.2024 • Final sample size: Target is 78 patients(including 10% dropouts)

Attached file